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Multiple defects and inter- atrial aneurysm are still limitation to any device closure. Fenestrated ASDs with and without aneurysm may need several 
devices placed across the atrial septum. In this study we are comparing these two different brands of special devices in closing the multi fenestrated 
ASDs Cribriform AGA and Helex Gore. Looking at technical aspects, procedure duration and residual shunts.
Between August 2003 and December 2007, 44 patients were diagnosed with fenestrated ASDs with and without septal aneurysm. They were 
scheduled for Cribriform or Helex device closure. The choice of the device was operator preference.
Attempted implantation with Cribriform device was done in 20 (group A) versus 24 patients had the newly modified Helex device (group B).
Device implantation procedure
Procedure was done under general anesthesia with simultaneous transesophageal echocardiography (TEE) performed in 36 patients or under 
sedation with intracardiac echocardiography (ICE) in 8 patients. We assessed defects diameter, intradefect distance, rims of superior, inferior and 
anterior AS, steady rim, total atrial septal length and the presence or absence of aneurysm as we reported previuosly.
Results: 
Group A (Cribriform) Group B (Helex) P value
Number of cases 20 24
Median Age (range) 13 years (2.5- 66) 15 years(2.5-64) 0.23
Median Wt (range) 44 Kg (13-96) 38 Kg (12-98) 0.35
Sex (F/M) 12/8 14/10
Qp/Qs (mean ± SD) 1.47/1 ± 0.3 1.7/1 ± 0.7
Atrial Septal Anuerysm (%) 11/20 (55%) 10/24 (42%) 0.35
Median number of fenestrations 3 3
Mean device Size 29.2 mm 25 mm
Qp/Qs (mean ± SD) 1.47/1 ± 0.3 1.7/1 ± 0.7 0.29
Procedure time (mean ± SD) 68.7 ± 29.5 min 92 ± 63 min 0.05
FluoroTime (mean ± SD) 10.8 ± 5.3 min 21 ± 9.7 min 0.06
RV mean diameter (before 
procedure)
27.3 mm 19.57 mm
RV mean diameter (6 months FU) 22.8 mm 13.3 mm
Failed implantation 2/20 (10%) 1/24 (4%) 0.06
Next day leak (%) 5/20 (25%) 3/24 (12%) 0.04
Last FU leak (%) 2/18 (11)% 1/21 (4%) 0.05
In conclusion both devices are safe and effective in closure of multiple ASDs. Helex devices had longer procedural and fluoro times but had less 
residual defects compared to Cribriform. The use of single device should replace the use of multiple devices to close multiple ASDs.
